CARL L GORDON Insider Trading Transactions
Get free email notifications about insider trading for CARL L GORDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARL L GORDON. CARL L GORDON is Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Arsanis, Inc. ($ASNS) and Director in Turning Point Therapeutics, Inc. ($TPTX) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in Alector, Inc. ($ALEC) and Director in Keros Therapeutics, Inc. ($KROS) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in Adicet Bio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Terns Pharmaceuticals, Inc. ($TERN).
Latest Insider Trading Transactions of CARL L GORDON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, ALEC, ARMO, NTLA, KROS, KNTE, ORIC, PRVL, SELB, TERN, TPTX, ASNS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Option Exercise | A | 15.93 | 18,500 | 294,705 | 18,500 | |
Mar 31 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.93 | 27,869 | 666,905 | 2,212,571 | 2.2 M to 2.2 M (-1.24 %) |
Mar 31 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.31 | 75,555 | 1,761,187 | 2,240,440 | 2.3 M to 2.2 M (-3.26 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.32 | 3,992 | 97,085 | 2,428,293 | 2.4 M to 2.4 M (-0.16 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 26.47 | 7,673 | 203,104 | 2,432,285 | 2.4 M to 2.4 M (-0.31 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 26.47 | 21,275 | 563,149 | 2,439,958 | 2.5 M to 2.4 M (-0.86 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 28.03 | 6,059 | 169,834 | 2,461,233 | 2.5 M to 2.5 M (-0.25 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 28.43 | 18,790 | 534,200 | 2,467,292 | 2.5 M to 2.5 M (-0.76 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 27.72 | 41,353 | 1,146,305 | 2,486,082 | 2.5 M to 2.5 M (-1.64 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 29.14 | 89,210 | 2,599,579 | 2,527,435 | 2.6 M to 2.5 M (-3.41 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 30.29 | 90,521 | 2,741,881 | 2,616,645 | 2.7 M to 2.6 M (-3.34 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 33.04 | 58,551 | 1,934,525 | 2,707,166 | 2.8 M to 2.7 M (-2.12 %) |
Feb 26 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | A | 22.06 | 25,000 | 551,500 | 25,000 | |
Feb 18 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 13.00 | 104,050 | 1,352,650 | 396,657 | 292.6 K to 396.7 K (+35.56 %) |
Feb 18 2021 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 13.00 | 420,299 | 5,463,887 | 5,243,259 | 4.8 M to 5.2 M (+8.71 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 918,295 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 612,196 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,071,428 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 714,285 | 0 | 0 | |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | P | 17.00 | 285,000 | 4,845,000 | 2,274,723 | 2 M to 2.3 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | P | 17.00 | 190,000 | 3,230,000 | 1,516,481 | 1.3 M to 1.5 M (+14.32 %) |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,989,723 | 0 | 1,989,723 | 0 to 2 M |
Feb 09 2021 | TERN | Terns Pharmaceutic ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,326,481 | 0 | 1,326,481 | 0 to 1.3 M |
Jan 26 2021 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
Jan 26 2021 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Sell | U | 0.00 | 13,822,463 | 0 | 0 | 13.8 M to 0 (-100.00 %) |
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 24,555 | 0 | 0 | ||
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 9,461 | 0 | 0 | ||
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 50,501 | 0 | 0 | ||
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 118,398 | 0 | 0 | ||
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 2,651,042 | 0 | 0 | ||
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Option Exercise | C | 0.00 | 243,494 | 0 | 0 | ||
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 24,637 | 0 | 84,599 | 60 K to 84.6 K (+41.09 %) | |
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 9,461 | 0 | 59,962 | 50.5 K to 60 K (+18.73 %) | |
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 50,501 | 0 | 50,501 | 0 to 50.5 K | |
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 118,794 | 0 | 3,313,330 | 3.2 M to 3.3 M (+3.72 %) | |
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 2,651,042 | 0 | 3,194,536 | 543.5 K to 3.2 M (+487.78 %) | |
Dec 09 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | C | 0.00 | 243,494 | 0 | 543,494 | 300 K to 543.5 K (+81.16 %) | |
Dec 04 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | P | 20.00 | 450,000 | 9,000,000 | 450,000 | 0 to 450 K | |
Dec 04 2020 | KNTE | Kinnate Biopharma ... | GORDON CARL L | Buy | P | 20.00 | 300,000 | 6,000,000 | 300,000 | 0 to 300 K | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 0.00 | 292,607 | 0 | 292,607 | 0 to 292.6 K |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 0.00 | 902,885 | 0 | 902,855 | -30 to 902.9 K (-3,009,616.67 %) |
Sep 17 2020 | TORC | Adicet Bio, Inc. | GORDON CARL L | Director | Grant | A | 0.00 | 4,822,960 | 0 | 4,822,960 | 0 to 4.8 M |
Jun 19 2020 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
Jun 17 2020 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | A | 65.39 | 8,500 | 555,815 | 8,500 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 236,111 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 373,356 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 236,111 | 0 | 2,765,717 | 2.5 M to 2.8 M (+9.33 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 373,356 | 0 | 2,529,606 | 2.2 M to 2.5 M (+17.32 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,875,000 | 0 | 2,156,250 | 281.3 K to 2.2 M (+666.67 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | P | 16.00 | 281,250 | 4,500,000 | 281,250 | 0 to 281.3 K |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 148,922 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 744,612 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | GORDON CARL L | Director | Buy | P | 16.00 | 375,200 | 6,003,200 | 1,119,812 | 744.6 K to 1.1 M (+50.39 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | GORDON CARL L | Director | Buy | C | 0.00 | 148,922 | 0 | 148,922 | 0 to 148.9 K |
Apr 13 2020 | KROS | Keros Therapeutics ... | GORDON CARL L | Director | Buy | C | 0.00 | 744,612 | 0 | 744,612 | 0 to 744.6 K |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,011,499 | 0 | 0 | |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 3,099,612 | 0 | 0 | |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 6,399,000 | 0 | 0 | |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Buy | P | 17.00 | 882,352 | 14,999,984 | 13,822,463 | 12.9 M to 13.8 M (+6.82 %) |
Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Buy | C | 0.00 | 10,510,111 | 0 | 12,940,111 | 2.4 M to 12.9 M (+432.51 %) |
May 14 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | A | 20.05 | 20,000 | 401,000 | 20,000 | |
Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,105,259 | 0 | 0 | |
Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 4,314,809 | 0 | 0 | |
Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Buy | P | 18.00 | 360,000 | 6,480,000 | 2,027,550 | 1.7 M to 2 M (+21.59 %) |
Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Buy | C | 0.00 | 546,820 | 0 | 1,667,550 | 1.1 M to 1.7 M (+48.79 %) |
Apr 24 2019 | TPTX | Turning Point Ther ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,120,730 | 0 | 1,120,730 | 0 to 1.1 M |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 85,295 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 266,437 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 234,601 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,012,282 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 528,510 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,280,479 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 470,374 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,029,626 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 992,437 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 4,282,288 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 94,075 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 405,925 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | P | 19.00 | 203,200 | 3,860,800 | 203,200 | 0 to 203.2 K |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | P | 19.00 | 50,561 | 960,659 | 2,455,853 | 2.4 M to 2.5 M (+2.10 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 85,295 | 0 | 2,405,292 | 2.3 M to 2.4 M (+3.68 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 234,601 | 0 | 2,319,997 | 2.1 M to 2.3 M (+11.25 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 528,510 | 0 | 2,085,396 | 1.6 M to 2.1 M (+33.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 470,374 | 0 | 1,556,886 | 1.1 M to 1.6 M (+43.29 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 992,437 | 0 | 1,086,512 | 94.1 K to 1.1 M (+1,054.94 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 94,075 | 0 | 94,075 | 0 to 94.1 K |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | P | 19.00 | 157,939 | 3,000,841 | 10,434,976 | 10.3 M to 10.4 M (+1.54 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 266,437 | 0 | 10,277,037 | 10 M to 10.3 M (+2.66 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 1,012,282 | 0 | 10,010,600 | 9 M to 10 M (+11.25 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 2,280,479 | 0 | 8,998,318 | 6.7 M to 9 M (+33.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 2,029,626 | 0 | 6,717,839 | 4.7 M to 6.7 M (+43.29 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 4,282,288 | 0 | 4,688,213 | 405.9 K to 4.7 M (+1,054.95 %) |
Feb 11 2019 | ALEC | Alector, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 405,925 | 0 | 405,925 | 0 to 405.9 K |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Sell | U | 50.00 | 409,547 | 20,477,350 | 0 | 409.5 K to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Sell | U | 50.00 | 3,709,356 | 185,467,800 | 0 | 3.7 M to 0 (-100.00 %) |
Jun 07 2018 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | A | 16.99 | 10,000 | 169,900 | 10,000 | |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 31,315 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 45,961 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 332,271 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 283,627 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 415,869 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,226,156 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,783,704 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Buy | C | 0.00 | 409,547 | 0 | 409,547 | 0 to 409.5 K |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Buy | C | 0.00 | 3,709,356 | 0 | 3,709,356 | 0 to 3.7 M |
Dec 01 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | A | 10.00 | 7,324 | 73,240 | 7,324 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,232,014 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 229,412 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 736,648 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 704,846 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 66,667 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,868,966 | 1.4 M to 1.9 M (+36.52 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 653,974 | 0 | 1,368,966 | 715 K to 1.4 M (+91.47 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 114,320 | 0 | 714,992 | 600.7 K to 715 K (+19.03 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 328,909 | 0 | 600,672 | 271.8 K to 600.7 K (+121.03 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 252,230 | 0 | 271,763 | 19.5 K to 271.8 K (+1,291.30 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 19,533 | 0 | 19,533 | 0 to 19.5 K |
May 19 2017 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | A | 14.35 | 19,000 | 272,650 | 19,000 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 456,870 | 0 | 0 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 4,351 | 0 | 0 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 77,697 | 0 | 0 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 739 | 0 | 0 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 380,986 | 0 | 0 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 3,628 | 0 | 0 | |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Buy | P | 14.00 | 544,811 | 7,627,354 | 1,825,415 | 1.3 M to 1.8 M (+42.54 %) |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Buy | P | 14.00 | 5,189 | 72,646 | 17,382 | 12.2 K to 17.4 K (+42.56 %) |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,166,884 | 0 | 1,280,604 | 113.7 K to 1.3 M (+1,026.10 %) |
Jun 29 2016 | SELB | SELECTA BIOSCIENCE ... | GORDON CARL L | Director | Buy | C | 0.00 | 11,111 | 0 | 12,193 | 1.1 K to 12.2 K (+1,026.89 %) |
May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 873,475 | 0 | 0 | |
May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,857,143 | 0 | 0 | |
May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | P | 18.00 | 58,534 | 1,053,612 | 2,662,180 | 2.6 M to 2.7 M (+2.25 %) |
May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | P | 18.00 | 191,466 | 3,446,388 | 2,603,646 | 2.4 M to 2.6 M (+7.94 %) |
May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | C | 0.00 | 564,780 | 0 | 2,412,180 | 1.8 M to 2.4 M (+30.57 %) |
May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,847,400 | 0 | 1,847,400 | 0 to 1.8 M |
May 09 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | A | 18.00 | 23,529 | 423,522 | 23,529 |
Page: 1